Sign in

CIK 0000730272

  • Large accelerated filer

REPLIGEN CORP

Sign in to watch
Ticker
RGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
042729386
Phone
+1 781-449-9560
Business address
41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,953,260
in 5 filings, $6.0M under 10b5-1 plans

Net −$5,953,260. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Loeillot Olivier −$6.0M Chief Executive Officer sold 41% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-03-02 Bylund James Chief Operating Officer Grant or award · Stock Option (Right to Buy) +8,644 8,644
2023-03-02 Hunt Anthony Chief Executive Officer Shares withheld for taxes −6,670 $176.37 $1.2M 165,574
2023-03-02 Gebski Christine See Remarks Shares withheld for taxes −630 $174.37 $110K 29,193
2023-02-28 Hunt Anthony Chief Executive Officer Shares withheld for taxes −2,748 $173.28 $476K 172,244
2023-02-28 Gebski Christine See Remarks Shares withheld for taxes −460 $173.28 $80K 29,823
2023-02-28 KURIYEL RALF Senior VP, R&D Shares withheld for taxes −358 $173.28 $62K 18,454
2023-02-28 Snodgres Jon Chief Financial Officer Shares withheld for taxes −521 $173.28 $90K 28,122
2023-02-28 Bylund James Chief Operating Officer Shares withheld for taxes −594 $173.44 $103K 9,139
2023-02-28 Hunt Anthony Chief Executive Officer Shares withheld for taxes −3,273 $173.44 $568K 174,992
2023-02-28 Snodgres Jon Chief Financial Officer Shares withheld for taxes −682 $173.44 $118K 28,643
2023-02-28 KURIYEL RALF Senior VP, R&D Shares withheld for taxes −458 $173.44 $79K 18,812
2023-02-28 Gebski Christine See Remarks Shares withheld for taxes −452 $173.44 $78K 30,283
2023-02-16 Snodgres Jon Chief Financial Officer Sale −5,647 $200.00 $1.1M 29,325
2023-02-06 Madaus Martin D Director Grant or award +111 111
2023-02-06 Madaus Martin D Director Grant or award · Stock Option (Right to Buy) +239 239
2023-02-06 Madaus Martin D Director Grant or award · Stock Option (Right to Buy) +1,819 1,819
2022-11-11 Hunt Anthony Chief Executive Officer Option exercise +25,000 $33.87 $847K 203,265
2022-11-11 Hunt Anthony Chief Executive Officer Sale −25,000 $200.00 $5.0M 178,265
2022-11-11 Hunt Anthony Chief Executive Officer Option exercise · Stock Option (Right to Buy) +25,000 34,246
2022-10-07 Snodgres Jon Chief Financial Officer Option exercise +466 $59.52 $28K 34,972

Page 17 of 23 · 455 trades